# Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

> **NCT00367393** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 41 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Pimecrolimus cream 1%

## Key facts

- **NCT ID:** NCT00367393
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367393, "Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00367393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*